These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31422074)

  • 21. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.
    Abdelmegeed MA; Banerjee A; Jang S; Yoo SH; Yun JW; Gonzalez FJ; Keshavarzian A; Song BJ
    Free Radic Biol Med; 2013 Dec; 65():1238-1245. PubMed ID: 24064383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of oxidative stress in non-alcoholic steatohepatitis].
    Mitsuyoshi H; Itoh Y; Okanoue T
    Nihon Rinsho; 2006 Jun; 64(6):1077-82. PubMed ID: 16768112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease.
    Liu W; Baker SS; Baker RD; Zhu L
    Curr Drug Targets; 2015; 16(12):1301-14. PubMed ID: 25915484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.
    Haque JA; McMahan RS; Campbell JS; Shimizu-Albergine M; Wilson AM; Botta D; Bammler TK; Beyer RP; Montine TJ; Yeh MM; Kavanagh TJ; Fausto N
    Lab Invest; 2010 Dec; 90(12):1704-17. PubMed ID: 20548286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function.
    Wolff G; Sakurai M; Mhamane A; Troullinaki M; Maida A; Deligiannis IK; Yin K; Weber P; Morgenstern J; Wieder A; Kwon Y; Sekar R; Zeigerer A; Roden M; Blüher M; Volk N; Poth T; Hackert T; Wiedmann L; De Angelis Rigotti F; Rodriguez-Vita J; Fischer A; Mukthavaram R; Limphong P; Tachikawa K; Karmali P; Payne J; Chivukula P; Ekim-Üstünel B; Martinez-Jimenez CP; Szendrödi J; Nawroth P; Herzig S
    Mol Metab; 2022 Jun; 60():101487. PubMed ID: 35378329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.
    Schröder T; Kucharczyk D; Bär F; Pagel R; Derer S; Jendrek ST; Sünderhauf A; Brethack AK; Hirose M; Möller S; Künstner A; Bischof J; Weyers I; Heeren J; Koczan D; Schmid SM; Divanovic S; Giles DA; Adamski J; Fellermann K; Lehnert H; Köhl J; Ibrahim S; Sina C
    Mol Metab; 2016 Apr; 5(4):283-295. PubMed ID: 27069868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
    Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
    Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity.
    Greatorex S; Kaur S; Xirouchaki CE; Goh PK; Wiede F; Genders AJ; Tran M; Jia Y; Raajendiran A; Brown WA; McLean CA; Sadoshima J; Watt MJ; Tiganis T
    J Clin Invest; 2023 Dec; 134(3):. PubMed ID: 38060313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice.
    Tomita K; Teratani T; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Nishiyama K; Mataki N; Irie R; Minamino T; Okada Y; Kurihara C; Ebinuma H; Saito H; Shimizu I; Yoshida Y; Hokari R; Sugiyama K; Hatsuse K; Yamamoto J; Kanai T; Miura S; Hibi T
    J Hepatol; 2012 Oct; 57(4):837-43. PubMed ID: 22641095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliverdin/Bilirubin Redox Pair Protects Lens Epithelial Cells against Oxidative Stress in Age-Related Cataract by Regulating NF-
    Huang Y; Li J; Li W; Ai N; Jin H
    Oxid Med Cell Longev; 2022; 2022():7299182. PubMed ID: 35480872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLR4 counteracts BVRA signaling in human leukocytes via differential regulation of AMPK, mTORC1 and mTORC2.
    Zhang Z; Amorosa LF; Petrova A; Coyle S; Macor M; Nair M; Lee LY; Haimovich B
    Sci Rep; 2019 May; 9(1):7020. PubMed ID: 31065010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Effects of Biliverdin Reductase a Deficiency in
    Bortolussi G; Shi X; Ten Bloemendaal L; Banerjee B; De Waart DR; Baj G; Chen W; Oude Elferink RP; Beuers U; Paulusma CC; Stocker R; Muro AF; Bosma PJ
    Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD
    Xie L; Wen K; Li Q; Huang CC; Zhao JL; Zhao QH; Xiao YF; Guan XH; Qian YS; Gan L; Wang LF; Deng KY; Xin HB
    Int J Biol Sci; 2021; 17(15):4305-4315. PubMed ID: 34803499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.
    Bettaieb A; Jiang JX; Sasaki Y; Chao TI; Kiss Z; Chen X; Tian J; Katsuyama M; Yabe-Nishimura C; Xi Y; Szyndralewiez C; Schröder K; Shah A; Brandes RP; Haj FG; Török NJ
    Gastroenterology; 2015 Aug; 149(2):468-80.e10. PubMed ID: 25888330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
    Di Ciaula A; Passarella S; Shanmugam H; Noviello M; Bonfrate L; Wang DQ; Portincasa P
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biliverdin reductase isozymes in metabolism.
    O'Brien L; Hosick PA; John K; Stec DE; Hinds TD
    Trends Endocrinol Metab; 2015 Apr; 26(4):212-20. PubMed ID: 25726384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
    Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
    J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes.
    Egnatchik RA; Leamy AK; Noguchi Y; Shiota M; Young JD
    Metabolism; 2014 Feb; 63(2):283-95. PubMed ID: 24286856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling PNPLA3-Associated NAFLD Using Human-Induced Pluripotent Stem Cells.
    Tilson SG; Morell CM; Lenaerts AS; Park SB; Hu Z; Jenkins B; Koulman A; Liang TJ; Vallier L
    Hepatology; 2021 Dec; 74(6):2998-3017. PubMed ID: 34288010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.